About PHA Staff

This author has not yet filled in any details.
So far PHA Staff has created 9 blog entries.

PHA to Introduce Newly Redesigned PH Resource at 6th World Symposium on Pulmonary Hypertension

2018-02-23T14:58:55-05:00February 23rd, 2018|

The 6th World Symposium on Pulmonary Hypertension will take place in Nice, France from Feb. 27 to March 1, 2018. This symposium, held every 5 years, is a time for global leaders in PH to review the major advances in the disease, analyze the evidence in studying and treating PH, and evaluate gaps of

Notice: PHA Phone Systems Experiencing Intermittent Outages

2018-02-20T20:58:48-05:00February 16th, 2018|

The Pulmonary Hypertension Association (PHA) office phone system is experiencing intermittent outages as of Friday, Feb. 16, 2018 at 9:45 a.m. EST. We are working on a solution as quickly as possible. If you need to contact PHA with general inquiries about membership, Conference, store orders or other questions, and are unable to reach us

PHA Accreditation Program Assures Access to Specialized Care for Thousands With Often-Misdiagnosed Deadly Lung Disease

2018-02-16T16:07:20-05:00February 16th, 2018|

Silver Spring, MD (February 15, 2018) – A national accreditation program launched by the Pulmonary Hypertension Association (PHA) assures that more than 12,000 people with a life-threatening lung disease are getting care from clinicians who specialize in their often-misdiagnosed condition. Pulmonary hypertension (PH), also known as high blood pressure of the lungs, affects adults

Seeking Financial Assistance Because of Caring Voice Developments? Previous CVC Clients Should Make That Clear When Contacting Manufacturers.

2018-02-16T16:16:51-05:00February 16th, 2018|

In January, the Department of Health and Humans Services informed companies that manufacture PH medications that they would be permitted to provide one year of free medication to some individuals who received assistance from the Caring Voice Coalition as of Nov. 28, 2017. To be eligible, a PH patient must have health insurance through a

Adding Immunoadsorption to Current Treatment for People With IPAH

2018-02-15T18:13:05-05:00February 15th, 2018|

Study looks at a theory that adding immunoadsorption, or the process of filtering out antibodies from the blood, in addition to other PH therapies may help improve outcomes for people with idiopathic pulmonary arterial hypertension. by Phyllis Hanlon, Contributing Writer   People with idiopathic pulmonary arterial hypertension (IPAH), a type of WHO Group 1 PH (PAH,

An Overview of Pulmonary Arterial Hypertension (PAH) and Lupus

2018-02-09T03:24:39-05:00February 9th, 2018|

WHO Group 1 PH (PAH, pulmonary arterial hypertension) can appear by itself of be associated with other medical conditions including connective tissue diseases (CTD), such as systemic lupus erythematosus (SLE). Although CTD-associated PAH is very common in people who have PAH, PAH is extremely uncommon among the many people with SLE. Because of this, a

Specialty Pharmacy Update on National Shortage of Diluent Used for Some PH Medications

2018-02-15T18:50:05-05:00February 2nd, 2018|

PHA was recently made aware of a national shortage of the diluent used for mixing some PH medications. The shortage is a result of product manufactures who have been affected by the 2017 hurricane season. The specialty pharmacies that deliver PH medications are working to monitor available supplies and purchase as much inventory as possible.

Researchers: Collect Data at Unique Opportunity in PH Field

2018-02-01T17:37:14-05:00February 1st, 2018|

Investigator Applications are now being accepted for the Research Room at PHA’s 2018 International PH Conference and Scientific Sessions. The Research Room helps researchers further their studies by providing the opportunity for collection of data, including phenotypic information and biological specimens, from the largest gathering of pulmonary hypertension patients in the world. Impact the field